✦ LIBER ✦

O-112. Aromatase inhibitors (AI) versus Tamoxifen for ER-positive breast cancer — a meta-analysis

Book ID: 118622538
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 207 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(05)80112-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-Analysis of Breast Cancer Outcomes

Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

✍ Dowsett, M.; Cuzick, J.; Ingle, J.; Coates, A.; Forbes, J.; Bliss, J.; Buyse, M. 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 255 KB

Meta-analysis of pre-operative aromatase

Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancer

✍ Jae Hong Seo; Yeul Hong Kim; Jun Suk Kim 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 254 KB

Aromatase Inhibitor Versus Tamoxifen in

Aromatase Inhibitor Versus Tamoxifen in Postmenopausal Woman With Advanced Breast Cancer: A Literature-Based Meta-Analysis

✍ Hong-Bin Xu; Yu-Jin Liu; Ling Li 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 352 KB

P79 Randomized Comparison of Adjuvant To

P79 Randomized Comparison of Adjuvant Toremifene (Tor) Versus Tamoxifen (Tam) for Postmenopausal Women with Node-Positive (N+), Estrogen Receptor-Positive (ER+) Early Stage Breast Cancer

✍ O. Pagani; S. Gelber; E. Simoncini; S. Holmberg; M. Colleoni; D. Crivellari; S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

5005 ORAL Exploratory Subgroup Analysis

5005 ORAL Exploratory Subgroup Analysis of the TAMRAD Phase 2 GINECO Trial Comparing Tamoxifen (TAM) Plus Everolimus (RAD) With TAM Alone in Patients With Hormone-receptor-positive, HER2-negative Metastatic Breast Cancer (mBC) With Prior Exposure to Aromatase Inhibitors (Als): Implication for Research Strategies

✍ Bourqier, C.; Ray-Coquard, I.; Provencal, J.; Cropet, C.; Bourcier, A.V.; Delecr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB